Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BM-MNC vs UC-MSC in Type 2 Diabetes
NCT04501341Phase 2Unknown
- Sponsor
- Universitas Indonesia
- Start
- Mar 2016
- Primary completion
- Dec 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone marrow-derived mononuclear cell, human umbilical cord mesenchymal stem cells in type 2 diabetes mellitus (T2DM), sponsored by Universitas Indonesia. Status: unknown.
02
Drugs
autologous bone marrow-derived mononuclear cellhuman umbilical cord mesenchymal stem cells
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04501341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04501341.